It is a healthcare private limited company based in T. Nagar, Tamil Nadu, India, established in 2017.
2017 | T. Nagar, Tamil Nadu, India | ActiveNavamin Pharmaceuticals Private Limited, a active private limited company, was established on 04 October 2017 in T. Nagar, Tamil Nadu, India. Engaging in medical equipment retail & distribution within the trade sector, it holds CIN: U74995TN2017PTC118910. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Dona Venkatesan Latha (Director), Donapadmanabha Venkatesan (Managing Director). It holds ₹3.75 Cr open charges and ₹7.50 M settled loans. Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at New No: 11/3 Old No: 6/3, Ii Floor, 4Th Street, Bharathi Nagar,, T. Nagar, Tamil Nadu, 600017.
U74995TN2017PTC118910
118910
04 October 2017
₹1.00 M
₹1.00 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Navamin Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dona Venkatesan Latha | Director | 04 Oct 2017 | Current |
| Donapadmanabha Venkatesan | Managing Director | 04 Oct 2017 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Navamin Pharmaceuticals Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 102.75% increase in profit. The company's net worth moved up by a moderate rise of 3.44%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Navamin Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹37,486,000.00
₹7,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jul 2018 | Canara Bank | ₹3.75 Cr | Open |
| 02 Jun 2020 | Canara Bank | ₹4.00 M | Satisfied |
| 04 Apr 2020 | Canara Bank | ₹3.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Navamin Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Navamin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Navamin Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 02 Jun 2020 via Charge ID 100385895 with Canara Bank was fully satisfied on 15 Jul 2021. was completed.
A charge registered on 04 Apr 2020 via Charge ID 100385946 with Canara Bank was fully satisfied on 15 Jul 2021. was recorded as a recent event.
A charge with Canara Bank of Rs. 37.49 M registered on 23 Jul 2018 with Charge ID 100208420 was modified on 08 Jul 2021. was recorded as a recent event.
Navamin Pharmaceuticals Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was recorded as a recent event.
Progress on A charge with Canara Bank amounted to Rs. 4.00 M with Charge ID 100385895 was registered on 02 Jun 2020. was documented.
The activity A charge with Canara Bank amounted to Rs. 3.50 M with Charge ID 100385946 was registered on 04 Apr 2020. was completed.
The CIN of Navamin Pharmaceuticals Private Limited is U74995TN2017PTC118910.
Navamin Pharmaceuticals Private Limited is headquartered at New No: 11/3 Old No: 6/3, Ii Floor, 4Th Street, Bharathi Nagar,, T. Nagar, Tamil Nadu, 600017.
Navamin Pharmaceuticals Private Limited was incorporated on 04 October 2017.
The current directors of Navamin Pharmaceuticals Private Limited are
The primary industry of Navamin Pharmaceuticals Private Limited is Trade.
Navamin Pharmaceuticals Private Limited is unlisted.
The authorized capital of Navamin Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Navamin Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX